Thams P, Geisler A
Acta Pharmacol Toxicol (Copenh). 1979 Nov;45(5):329-35. doi: 10.1111/j.1600-0773.1979.tb02401.x.
Lithium inhibits in vitro as well as in vivo several hormone-stimulated adenylate cyclases. The aim of this study was to investigate the mechanism by which lithium inhibits adenylate cyclase in vitro. It was found that lithium inhibited both the norepinephrine- and the glucagon-induced cAMP accumulation in rat fat cells at lithium concentrations above 10 mM. The basal cAMP content was unaffected even at 40 mM of lithium. The inhibitory action was time-dependent and reversible, indicating an intracellular site of action. Lithium inhibited both norepinephrine- and glucagon-stimulated cAMP accumulation in a mainly non-competitive way, but the inhibitory effect decreased with increasing hormone concentrations. In accordance, lithium and propranolol had a supraadditive effect on norepinephrine-induced cAMP accumulation. It is suggested that lithium affects both the hormone-receptor binding as well as the transfer of the hormonal stimulus by an intracellular site of action.
锂在体外和体内均可抑制多种激素刺激的腺苷酸环化酶。本研究的目的是探讨锂在体外抑制腺苷酸环化酶的机制。研究发现,当锂浓度高于10 mM时,锂可抑制大鼠脂肪细胞中去甲肾上腺素和胰高血糖素诱导的cAMP积累。即使在40 mM锂的情况下,基础cAMP含量也未受影响。这种抑制作用具有时间依赖性且可逆,表明其作用位点在细胞内。锂主要以非竞争性方式抑制去甲肾上腺素和胰高血糖素刺激的cAMP积累,但随着激素浓度的增加,抑制作用减弱。相应地,锂和普萘洛尔对去甲肾上腺素诱导的cAMP积累具有超相加作用。提示锂通过细胞内作用位点影响激素-受体结合以及激素刺激的传递。